D. E. Shaw & Co., Inc. Stoke Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 171,246 shares of STOK stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

171,246

Holding current value

$1.97 Million

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$12.24 - $15.92 $419,048 - $545,037	34,236 Added 24.99%	171,246 $2.1 Million
Q2 2024 Aug 14, 2024	SELL	$11.03 - $17.52 $625,952 - $994,260	-56,750 Reduced 29.29%	137,010 $1.85 Million
Q1 2024 May 15, 2024	BUY	$4.12 - $14.17 $210,321 - $723,364	51,049 Added 35.77%	193,760 $2.62 Million
Q4 2023 Feb 14, 2024	SELL	$3.37 - $5.4 $210,473 - $337,257	-62,455 Reduced 30.44%	142,711 $750,000
Q3 2023 Nov 14, 2023	BUY	$3.78 - $11.99 $335,289 - $1.06 Million	88,701 Added 76.16%	205,166 $808,000
Q2 2023 Aug 14, 2023	BUY	$7.93 - $13.82 $400,433 - $697,854	50,496 Added 76.55%	116,465 $1.24 Million
Q1 2023 May 15, 2023	SELL	$7.65 - $10.38 $21,924 - $29,749	-2,866 Reduced 4.16%	65,969 $549,000
Q4 2022 Feb 14, 2023	BUY	$7.07 - $15.69 $301,889 - $669,963	42,700 Added 163.38%	68,835 $635,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $328,255 - $588,821	26,135 New	26,135 $336,000
Q1 2022 May 16, 2022	SELL	$17.19 - $26.1 $173,017 - $262,696	-10,065 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$18.11 - $30.72 $182,277 - $309,196	10,065 New	10,065 $241,000
Q3 2021 Nov 15, 2021	SELL	$23.65 - $34.44 $168,931 - $246,004	-7,143 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$30.53 - $41.09 $143,918 - $193,698	-4,714 Reduced 39.76%	7,143 $240,000
Q1 2021 May 17, 2021	BUY	$36.08 - $69.81 $427,800 - $827,737	11,857 New	11,857 $461,000

Others Institutions Holding STOK

# of Institutions

125

Shares Held

57.6M

Call Options Held

9.3K

Put Options Held

35.2K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $453M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account